| Title : Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs - Yamada_1997_Neurosci.Lett_225_25 |
| Author(s) : Yamada S , Fujii T , Kawashima K |
| Ref : Neuroscience Letters , 225 :25 , 1997 |
| Abstract : Yamada_1997_Neurosci.Lett_225_25 |
| ESTHER : Yamada_1997_Neurosci.Lett_225_25 |
| PubMedSearch : Yamada_1997_Neurosci.Lett_225_25 |
| PubMedID: 9143009 |
Yamada S, Fujii T, Kawashima K (1997)
Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs
Neuroscience Letters
225 :25
Yamada S, Fujii T, Kawashima K (1997)
Neuroscience Letters
225 :25